Abstract Body

Viruses rely heavily on host cellular machinery to replicate. In turn, cells have evolved elaborate defense mechanisms to impede virus replication. Numerous cellular proteins, often referred to as inhibitory or restriction factors, are central components of the innate immune response that serves as the first line of defense against invading pathogens. In recent years, several families of host proteins have been shown to inhibit the function of a wide range of viral envelope glycoproteins, thereby blocking virus infection. These include the IFITM proteins, guanylate binding protein 5, the SERINC proteins, and the membrane-associated RING-CH (MARCH) family of RING-finger E3 ubiquitin ligases. MARCH proteins downregulate cell-surface proteins involved in adaptive immunity. The RING-CH domain of MARCH proteins is hypothesized to ubiquitinate the cytoplasmic tails (CTs) of target proteins leading to their proteasomal or lysosomal degradation. Three MARCH proteins (MARCH1, 2, and 8) have recently been reported to target the HIV-1 envelope glycoprotein (Env) and vesicular stomatitis virus G glycoprotein (VSV-G), thereby impairing the infectivity of HIV-1 virions bearing these glycoproteins. We show that MARCH protein expression is rapidly induced by interferon (IFN) treatment and that the antiviral activity of MARCH proteins extends to the Ebola virus glycoprotein (EboV-GP) and the SARS-CoV-2 spike (S) protein. We observe that MARCH protein targeting of VSV-G is to a large extent CT-dependent. In contrast, MARCH-protein targeting of HIV-1 Env, EboV-GP, and SARS-CoV-2 S protein does not require the CT, indicating that MARCH-mediated inhibition of these viral glycoproteins is likely indirect and via targeting a cellular host factor(s) involved in glycoprotein trafficking. Confocal microscopy data demonstrate that MARCH proteins are able to trap the viral glycoproteins in an intracellular compartment bearing lysosomal markers. These results clarify the mechanism by which MARCH proteins antagonize viral glycoproteins and provide insights into the antiviral role of cellular inhibitory factors in Env biogenesis, trafficking, and virion incorporation.